biotech
Bio-AnalystSupplement research
person

Betaine

Nutrient status

Human studies reported a change with no confirmed comparison group in homocysteine; while Studies with an unspecified organism reported a change with no confirmed comparison group in homocysteine.

Single-ingredient studies · Human studies · Population not specified · comparator not confirmed

Publications for this result: 2

Other outcomes and study details

Distinct publications linked to this topic: 14

  • Study conditions differ; results are shown descriptively and are not pooled.

What has been studied?

Distinct human comparison papers: 3

Some studies tested several ingredients together. Those results cannot show this ingredient’s separate effect or establish synergy.

  • Fasting plasma homocysteine

    • Comparison result:A better result than the comparison group was reported.
      General population · Single ingredient · 6 weeks
      Measurement and study conditions
      • Controlled human study
      • Controlled trial
      • Single ingredient
      • General population
      • Primary outcome
      • Between-group comparison
      • Timepoint: 6 weeks
      • Study comparison: Betaine versus placebo for fasting plasma homocysteine after overnight fast
  • homocysteine

    Other human research, including observational studies and reviews
    • A change was reported, but the comparison could not be confirmed.
      Single ingredient
      Measurement and study conditions
      • Controlled human study
      • Randomized trial
      • Single ingredient
      • Unspecified population
      • Outcome role not specified
      • Timepoint: unspecified
      • Study comparison: unspecified
    Research with unclear study subject or type
    • A change was reported, but the comparison could not be confirmed.
      General population · Single ingredient
      Measurement and study conditions
      • Meta-analysis
      • Meta-analysis
      • Single ingredient
      • General population
      • Biomarker
      • Study subject not identified
      • Timepoint: unspecified
      • Study comparison: Betaine supplementation versus study comparators across included studies; dose subgroup findings wer
  • Homocysteine concentration

    Other human research, including observational studies and reviews
    • A change was reported, but the comparison could not be confirmed.
      Patient group · Single ingredient
      Measurement and study conditions
      • Controlled human study
      • Randomized trial
      • Single ingredient
      • Patient group
      • Outcome role not specified
      • Timepoint: unspecified
      • Study comparison: unspecified
  • Plasma homocysteine concentration

    • Comparison result:A better result than the comparison group was reported.
      Combination study
      Measurement and study conditions
      • Controlled human study
      • Randomized trial
      • Ingredient combination
      • Unspecified population
      • Outcome role not specified
      • Between-group comparison
      • Timepoint: unspecified
      • Study comparison: unspecified
    • Comparison result:A better result than the comparison group was reported.
      Single ingredient
      Measurement and study conditions
      • Controlled human study
      • Randomized trial
      • Single ingredient
      • Unspecified population
      • Outcome role not specified
      • Between-group comparison
      • Timepoint: unspecified
      • Study comparison: unspecified
Other measured outcomes (3)
  • post-methionine load tHcy

    Research with unclear study subject or type
    • A change was reported, but the comparison could not be confirmed.
      Deficiency group · Single ingredient
      Measurement and study conditions
      • Review
      • Review
      • Single ingredient
      • Deficiency group
      • Biomarker
      • Study subject not identified
      • Timepoint: unspecified
      • Study comparison: review-level summary of betaine supplementation and post-methionine load
  • tHcy

    Other human research, including observational studies and reviews
    • An association was observed. This does not establish that the ingredient caused the change.
      General population · Single ingredient
      Measurement and study conditions
      • Observational study
      • Observational study
      • Single ingredient
      • General population
      • Biomarker
      • Comparison unclear
      • Timepoint: unspecified
      • Study comparison: individual betaine intake; combined betaine+choline had only a weak trend
  • total area under the plasma homocysteine-time curve after methionine loading

    • Comparison result:A better result than the comparison group was reported.
      General population · Single ingredient · 6 weeks
      Measurement and study conditions
      • Controlled human study
      • Controlled trial
      • Single ingredient
      • General population
      • Secondary outcome
      • Between-group comparison
      • Timepoint: 6 weeks
      • Study comparison: Betaine versus placebo after methionine loading

This result is held for interpretation. That does not mean research found no effect.

Outcome groups needing additional review (2)
  • homocysteine concentrations · Distinct papers needing additional review: 1Direction unclear: 1
  • increased plasma homocysteine · Distinct papers needing additional review: 1Evidence criteria check: 1

One paper can appear under multiple measured outcomes or review reasons, so these counts should not be added together.

Research topics to explore

Research topics to explore

Review findings reported in each research area.

Topics with more linked papers appear first.

  • Nutrient status

    Related papers 14 · human comparison papers 3

    View selected result
  • Glucose and metabolic health

    Related papers 5 · human comparison papers 1

    View results
    • Body fat percentage · Improvement reported
    • blood glucose concentrations · Interpretation held

    More outcome groups: 3

  • Exercise performance

    Related papers 4 · human comparison papers 2

    View results
    • repetitions · Improvement reported
    • ∆IGF-1 · Improvement reported

    More outcome groups: 1

  • Blood lipids

    Related papers 2 · human comparison papers 1

    View results
    • LDL cholesterol · Worsening reported
  • Stress and mood

    Related papers 2 · comparison findings need further review

    View results
    • Depression · Interpretation held
  • Blood pressure and vascular health

    Related papers 1 · comparison findings need further review

    View results
    • systolic blood pressure (SBP) and diastolic blood pressure (DBP) · Some studies included patients or people with a deficiency · Comparison details unconfirmed
  • Fatigue and energy

    Related papers 1 · comparison findings need further review

    View results
    • fatigue · Comparison details unconfirmed
  • Men's health

    Related papers 1 · human comparison papers 1

    View results
    • Testosterone level · Improvement reported
Data coverage and detailed study classifications

Paper counts are separated by research topic below. One paper may contribute to multiple findings.

Analysis status: Public-ready

Ingredient analysis date:

How the grade was determined: B

The 62.7 evidence score includes 3 independent human studies and 3 clinical studies in the representative benefit area. The B tier remains conservative because of the evidence centers on contextual or measured outcomes rather than general-use effects, limited repetition across independent human clinical studies.

The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.

Papers linked to this ingredient overall: 60

Papers linked to this topic 14 · distinct papers 14 · papers with a confirmed human comparison 3 · papers needing additional review 6

Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.

  • Fasting plasma homocysteine: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
  • homocysteine: Sources represented in this measurement group: 2 · Distinct papers with human comparisons for this outcome: 0
  • Homocysteine concentration: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • homocysteine concentrations: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • increased plasma homocysteine: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • Plasma homocysteine concentration: Sources represented in this measurement group: 2 · Distinct papers with human comparisons for this outcome: 2
  • post-methionine load tHcy: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • tHcy: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • total area under the plasma homocysteine-time curve after methionine loading: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1

Nutrient status

What the research found

Fasting plasma homocysteine

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

plasma homocysteine concentration

The study reported improvement in this measurement.

Controlled study in people · Ingredient combination · Unspecified population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Plasma homocysteine concentration

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

total area under the plasma homocysteine-time curve after methionine loading

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

tHcy

An association was observed. This does not establish that the ingredient caused the change.

Observational study · Single ingredient · General population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

homocysteine

A change was reported, but the comparison could not be confirmed.

Controlled study in people · Single ingredient · Unspecified population

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

homocysteine

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Single ingredient · General population

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Homocysteine concentration

A change was reported, but the comparison could not be confirmed.

Controlled study in people · Single ingredient · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

post-methionine load tHcy

A change was reported, but the comparison could not be confirmed.

Review · Single ingredient · Deficiency group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

homocysteine concentrations

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

increased plasma homocysteine

The study needs further checking before its result can be interpreted.

Review · Single ingredient · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Other evidence · Unknown intervention · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Glucose and metabolic health

What the research found

Body fat percentage

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

risk of T2D

An association was observed. This does not establish that the ingredient caused the change.

Observational study · Unknown intervention · General population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

risk of type 2 diabetes

An association was observed. This does not establish that the ingredient caused the change.

Observational study · Unknown intervention · General population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

serum glucose concentrations

An association was observed. This does not establish that the ingredient caused the change.

Observational study · Single ingredient · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

blood glucose concentrations

The study needs further checking before its result can be interpreted.

Animal study · indirect · Single ingredient · General population

This finding comes from animal or cell research. It does not establish the same effect in people.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Exercise performance

What the research found

back squat

A change was reported before and after use. Its cause cannot be isolated.

Controlled study in people · Single ingredient · General population

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

repetitions

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

∆IGF-1

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Blood lipids

What the research found

LDL cholesterol

The study reported worsening in this measurement.

Controlled study in people · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Meta-analysis · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Stress and mood

What the research found

Depression

The study needs further checking before its result can be interpreted.

Other evidence · Single ingredient · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Other evidence · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Blood pressure and vascular health

What the research found

systolic blood pressure (SBP) and diastolic blood pressure (DBP)

An association was observed. This does not establish that the ingredient caused the change.

Observational study · Unknown intervention · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Fatigue and energy

What the research found

fatigue

A change was reported, but the comparison could not be confirmed.

Controlled study in people · Single ingredient · Unspecified population

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Men's health

What the research found

Testosterone level

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

How to read research findings

How should I read research findings?

Research guides

Side effects and combination findings

Findings from this ingredient alone are shown separately from those involving another supplement or medication.

Caution findings
1
Findings from individual and combined use, plus reviewed cautions
Key precautions
No reviewed caution rules are available yet. Reported caution findings are shown below.
These findings were reported in studies. They do not predict an individual's experience.

Findings to review with care

Side effects reported for the ingredient alone are separated from findings involving another supplement or medication.

Side effects reported with this ingredient alone

Symptoms or adverse events reported in studies without another active ingredient.

ALT1 papers
Betaine at doses of 2–8 g/day for 12–24 weeks significantly reduced ALT and other liver injury markers in 70 participants with MASLD, with mild transient GI symptoms reported in ~35 %.Human studies · Randomized controlled trial